Biological Products, (No Diagnostic Substances) Industry - SEC Form 4 Insider Trading Screener

Manufacturing Sector - Chemicals - Biological Products, (No Diagnostic Substances)
General
Tickers
Insider
Sh Price $
Lqdty M$
Date
Filing Date
  
Trade Date
  
Filing Delay
N Days Ago
Transaction Filing
P - Purchase
S - Sale
A - Grant
D - Sale to Iss
G - Gift
F - Tax
M - Option Ex
X - Option Ex
C - Cnv Deriv
W - Inherited
No deriv Multiple Days
Traded K$
Own Chg %
Industry
Insider Title   Officer
    COB
    CEO
    Pres
    COO
    CFO
    GC
    VP
  Director
  10% Own
  Other
Group by
Sort by
Max Results
Page
clear
Real-time CSV, Options, Alerts
100 results - Yahoo - Google - Finviz - Stockcharts - Tradingview - Stocktwits - SEC
TCcnt1d1w1m6m

X

Filing Date

Trade Date

Ticker

Company

Insider Name

Insider Title

Trade Type 

Share Price

Shares Traded

Shares Owned

Own chg

Value Traded

1d ret

1w ret

1m ret

6m ret

2018-02-20
GILDGilead Sciences IncAlton Gregg HEVP,Corporate,Medical AffairsS - Sale$81.54-14,4350-100%-$1,176,992
2018-02-20
BIIBBiogen Inc.Sandrock AlfredEVP, Chief Medical OfficerS - Sale$292.00-7436,553-10%-$216,956
D
2018-02-16
ATRAAtara Biotherapeutics, Inc.Gallagher Carol GiltnerDirS - Sale+OE$46.50-1,183110,920-1%-$55,010
DM
2018-02-15
ATRAAtara Biotherapeutics, Inc.McGrath JohnEVP, CFOS - Sale+OE$47.07-13,00094,762-12%-$611,925
DM
2018-02-15
ATRAAtara Biotherapeutics, Inc.Ciechanover Isaac E.CEOS - Sale+OE$46.92-20,0001,055,491-2%-$938,459
2018-02-15
BIIBBiogen Inc.Sandrock AlfredEVP, Chief Medical OfficerS - Sale$298.85-1,2947,296-15%-$386,712
2018-02-15
LJPCLa Jolla Pharmaceutical CoPerceptive Advisors LLC10%P - Purchase$32.42+50,0003,613,611+1%+$1,621,000
2018-02-15
NBIXNeurocrine Biosciences IncLyons Gary ADirS - Sale$84.67-5,000262,066-2%-$423,341
DM
2018-02-14
EDITEditas Medicine, Inc.Hack Andrew A. F.CFOS - Sale+OE$34.21-18,0000-100%-$615,840
2018-02-14
AMGNAmgen IncHarper Sean EEVP, Research, DevelopmentS - Sale$174.18-1,52552,089-3%-$265,625
A
2018-02-12
JUNOJuno Therapeutics, Inc.Azelby RobertEVP, Chief Commercial OfficerS - Sale$85.55-4,15989,612-4%-$355,802
M
2018-02-13
LJPCLa Jolla Pharmaceutical CoPerceptive Advisors LLC10%P - Purchase$32.72+175,0003,563,611+5%+$5,725,250
D
2018-02-13
TECHBio-Techne CorpDinarello Charles ADirS - Sale+OE$136.06-5,0008,212-38%-$680,303
M
2018-02-13
ATRAAtara Biotherapeutics, Inc.Ciechanover Isaac E.CEOS - Sale$46.80-20,0001,071,553-2%-$935,956
2018-02-12
JUNOJuno Therapeutics, Inc.Azelby RobertEVP, Chief Commercial OfficerS - Sale$85.55-4,15789,614-4%-$355,631
D
2018-02-14
MNTAMomenta Pharmaceuticals IncStorer Scott MSVP, CFOS - Sale+OE$15.16-3,97244,783-8%-$60,216
DM
2018-02-12
MNTAMomenta Pharmaceuticals IncWheeler Craig APres, CEOS - Sale+OE$16.14-18,648617,142-3%-$301,050
DM
2018-02-12
MNTAMomenta Pharmaceuticals IncKaundinya Ganesh VenkataramanCOO, CSOS - Sale+OE$15.23-4,986496,045-1%-$75,942
DM
2018-02-12
MNTAMomenta Pharmaceuticals IncLeicher BruceSVP, GCS - Sale+OE$15.22-4,948171,571-3%-$75,333
D
2018-02-09
SGENSeattle Genetics Inc /waSiegall Clay BPres, CEOS - Sale+OE$49.75-18,832687,146-3%-$936,818
D
2018-02-09
GILDGilead Sciences IncWilson Gayle EDirS - Sale+OE$77.92-60,000122,258-33%-$4,675,080
DM
2018-02-09
NBIXNeurocrine Biosciences IncGrigoriadis Dimitri E.CHIEF RESEARCH OFFICERS - Sale+OE$78.32-86,36882,942-51%-$6,764,173
2018-02-12
VYGRVoyager Therapeutics, Inc.Ravina BernardChief Medical OfficerS - Sale$18.24-2,4514,902-33%-$44,706
2018-02-09
ATRAAtara Biotherapeutics, Inc.Turner Heather DFormer EVP, GC, Sec.S - Sale$38.01-12,21469,494-15%-$464,210
M
2018-02-08
ATRAAtara Biotherapeutics, Inc.Ciechanover Isaac E.CEOS - Sale$37.44-8,8001,091,553-1%-$329,429
D
2018-02-08
MNTAMomenta Pharmaceuticals IncWheeler Craig APres, CEOS - Sale+OE$15.89-10,406635,790-2%-$165,351
D
2018-02-08
MNTAMomenta Pharmaceuticals IncLeicher BruceSVP, GCS - Sale+OE$16.00-1,861176,519-1%-$29,776
D
2018-02-08
MNTAMomenta Pharmaceuticals IncKaundinya Ganesh VenkataramanCOO, CSOS - Sale+OE$16.00-1,917490,9280%-$30,672
D
2018-02-08
JUNOJuno Therapeutics, Inc.Azelby RobertEVP, Chief Commercial OfficerS - Sale+OE$85.77-3,49793,771-4%-$299,938
D
2018-02-08
LIFEAtyr Pharma IncBlake John TSVP, FinanceS - Sale+OE$3.40-1,4021,932-42%-$4,767
D
2018-02-08
LIFEAtyr Pharma IncAmanullah AshrafSee RemarksS - Sale+OE$3.40-1,4021,932-42%-$4,767
D
2018-02-05
NBIXNeurocrine Biosciences IncObrien Christopher FlintFormer Chief Medical OfficerS - Sale+OE$83.18-2,61355,946-4%-$217,341
2018-02-05
NBIXNeurocrine Biosciences IncLyons Gary ADirS - Sale$83.08-5,000267,066-2%-$415,380
D
2018-02-05
NBIXNeurocrine Biosciences IncLloyd-Smith MalcolmChief Regulatory OfficerS - Sale+OE$83.19-96015,318-6%-$79,863
D
2018-02-05
NBIXNeurocrine Biosciences IncLippoldt DarinGCS - Sale+OE$83.12-2,73716,062-15%-$227,494
D
2018-02-05
NBIXNeurocrine Biosciences IncGrigoriadis Dimitri E.CHIEF RESEARCH OFFICERS - Sale+OE$83.09-2,04682,942-2%-$169,997
DM
2018-02-05
NBIXNeurocrine Biosciences IncGorman Kevin CharlesCEOS - Sale+OE$80.25-105,983347,033-23%-$8,504,784
D
2018-02-05
NBIXNeurocrine Biosciences IncBozigian Haig P.CHIEF DEVELOPMENT OFFICERS - Sale+OE$83.10-2,262135,997-2%-$187,977
D
2018-02-05
NBIXNeurocrine Biosciences IncBenevich EricChief Commercial OfficerS - Sale+OE$83.14-8204,310-16%-$68,174
D
2018-02-05
NBIXNeurocrine Biosciences IncGano KyleChief Business Development OffS - Sale+OE$83.05-2,04679,446-3%-$169,914
D
2018-02-06
SGMOSangamo Therapeutics, IncConner Edward R.SVP, Chief Medical OfficerS - Sale+OE$18.49-5,0008,125-38%-$92,436
D
2018-02-01
GILDGilead Sciences IncAlton Gregg HEVP,Corporate,Medical AffairsS - Sale+OE$83.51-25,00037,738-40%-$2,087,860
D
2018-02-01
GILDGilead Sciences IncMartin John CExec COBS - Sale+OE$83.56-50,0002,996,766-2%-$4,177,824
D
2018-02-01
SGMOSangamo Therapeutics, IncMento Steven JDirS - Sale+OE$20.59-11,52035,694-24%-$237,159
D
2018-02-01
SGMOSangamo Therapeutics, IncHerberts Curt A. IIISr.VP, Chief Business OfficerS - Sale+OE$20.59-15,00014,625-51%-$308,855
2018-02-01
EDITEditas Medicine, Inc.Bosley KatrinePres, CEOS - Sale$36.18-8,3331,336,098-1%-$301,451
D
2018-02-01
AVXSAvexis, Inc.Nagendran SukumarSVP, Chief Medical OfficerS - Sale+OE$117.96-1,7800-100%-$209,969
2018-02-01
AVXSAvexis, Inc.Kaspar Brian K.Chief Scientific OfficerS - Sale$118.07-15,0001,781,802-1%-$1,771,010
D
2018-02-01
AVXSAvexis, Inc.Knudten Andrew F.SrVP, Manufacture, Supply ChaiS - Sale+OE$118.13-2,0005,000-29%-$236,253
D
2018-02-01
BLUEBluebird Bio, Inc.Gregory Philip DChief Scientific OfficerS - Sale+OE$204.90-2,25031,272-7%-$461,020
D
2018-02-02
BLUEBluebird Bio, Inc.Davidson DavidChief Medical OfficerS - Sale+OE$202.36-4,00024,905-14%-$809,441
2018-02-01
SGENSeattle Genetics Inc /waBaker Bros. Advisors LPDir, 10%P - Purchase$52.00+3,846,15349,848,524+8%+$199,999,956
D
2018-02-01
JUNOJuno Therapeutics, Inc.Azelby RobertEVP, Chief Commercial OfficerS - Sale+OE$85.78-4,16796,471-4%-$357,445
D
2018-01-30
SLDBSolid Biosciences Inc.Koppel AdamDirP - Purchase$16.00+300,0001,989,444+18%+$4,800,000
D
2018-01-30
MNTAMomenta Pharmaceuticals IncStoner ElizabethDirS - Sale+OE$18.00-16,26416,176-50%-$292,752
D
2018-01-30
BLUEBluebird Bio, Inc.High Susanna GattiCOOS - Sale+OE$195.91-17,26211,250-61%-$3,381,792
D
2018-01-30
BLUEBluebird Bio, Inc.Cole JasonGCS - Sale+OE$195.91-25,00019,798-56%-$4,897,743
2018-01-31
NVAXNovavax IncGlenn Gregory MPres, R, DP - Purchase$0.88+12,78427,211+89%+$11,250
M
2018-01-29
EDITEditas Medicine, Inc.Bosley KatrinePres, CEOS - Sale$38.79-20,0001,344,431-1%-$775,860
2018-01-30
SLDBSolid Biosciences Inc.Shah Rajeev M.DirP - Purchase$16.00+1,000,0002,689,444+59%+$16,000,000
2017-05-30
JUNOJuno Therapeutics, Inc.Flatley Jay TDirP - Purchase$22.92+10,00031,500+47%+$229,200
2018-01-30
SLDBSolid Biosciences Inc.Perceptive Advisors LLCDir, 10%P - Purchase$16.22+1,020,0003,927,222+35%+$16,546,520
D
2018-01-26
JNCEJounce Therapeutics, Inc.Duncan Barbara GayleDirS - Sale+OE$25.00-4,0000-100%-$100,000
M
2018-01-25
ATRAAtara Biotherapeutics, Inc.Ciechanover Isaac E.CEOS - Sale$35.26-19,3001,035,353-2%-$680,534
2018-01-22
VICLVical IncArmistice Capital, LLC10%P - Purchase$1.43+100,0004,600,000+2%+$143,025
D
2018-01-24
NBIXNeurocrine Biosciences IncRastetter William HDirS - Sale+OE$90.00-9,50024,750-28%-$855,000
D
2018-01-25
ASTAsterias Biotherapeutics, Inc.Mulroy Michael H.Pres, CEOP - Purchase$2.34+2,1349,933+27%+$5,000
2018-01-23
EDITEditas Medicine, Inc.Bosley KatrinePres, CEOS - Sale$35.28-3,3381,364,4310%-$117,765
M
2018-01-22
ATRAAtara Biotherapeutics, Inc.Ciechanover Isaac E.CEOS - Sale$34.58-48,5001,404,131-3%-$1,677,279
D
2018-01-22
JUNOJuno Therapeutics, Inc.Azelby RobertEVP, Chief Commercial OfficerS - Sale+OE$86.25-102,53970,832-59%-$8,843,989
2018-01-22
RGENRepligen CorpHunt AnthonyCEOS - Sale$35.95-8,97083,613-10%-$322,445
2018-01-22
RGNXRegenxbio Inc.Mills Kenneth T.Pres, CEOS - Sale$27.33-10,000248,530-4%-$273,300
D
2018-01-19
ACORAcorda Therapeutics IncWasman JanePres, Intl, GCS - Sale+OE$27.59-34,520102,110-25%-$952,319
2017-12-08
ONCESpark Therapeutics, Inc.Furey JohnCOOP - Purchase$73.48+180-100%+$1,323
2017-12-11
ONCESpark Therapeutics, Inc.Furey JohnCOOS - Sale$46.33-180-100%-$834
M
2018-01-17
CVMCel Sci CorpTalor EyalCSOS - Sale$2.06-8,192111,257-7%-$16,876
DM
2018-01-18
ACORAcorda Therapeutics IncLawrence DavidChief, Bus. Ops, PAOS - Sale+OE$27.58-31,0004,693-87%-$854,911
D
2018-01-17
JUNOJuno Therapeutics, Inc.Azelby RobertEVP, Chief Commercial OfficerS - Sale+OE$68.61-29,13170,832-29%-$1,998,603
2018-01-17
IDRAIdera Pharmaceuticals, Inc.Pillar Invest Corp10%S - Sale$2.40-200,0000-100%-$480,000
2018-01-17
GNCAGenocea Biosciences, Inc.Clark William DPres, CEOP - Purchase$0.80+25,00082,931+43%+$20,000
D
2018-01-16
JUNOJuno Therapeutics, Inc.Bishop Hans EdgarCEO, PresS - Sale+OE$46.17-270,2502,502,429-10%-$12,478,528
D
2018-01-16
GILDGilead Sciences IncMeyers James REVP Worldwide Commercial OpsS - Sale+OE$80.24-100,0002,715-97%-$8,024,364
D
2018-01-16
CRSPCrispr Therapeutics AGDylan-Hyde TylerGCS - Sale+OE$28.03-66,00025,204-72%-$1,850,255
2018-01-16
ATRAAtara Biotherapeutics, Inc.Ciechanover Isaac E.CEOS - Sale$30.38-6001,103,1530%-$18,228
M
2018-01-12
CVMCel Sci CorpTalor EyalCSOS - Sale$2.15-1,808119,449-1%-$3,887
2018-01-16
RGNXRegenxbio Inc.Vasista VittalCFOS - Sale$30.16-5,000107,283-4%-$150,800
2018-01-16
NBIXNeurocrine Biosciences IncObrien Christopher FlintCHIEF MEDICAL OFFICERS - Sale$79.14-1,75050,723-3%-$138,499
2018-01-16
NBIXNeurocrine Biosciences IncGrigoriadis Dimitri E.CHIEF RESEARCH OFFICERS - Sale$79.12-1,62579,316-2%-$128,563
2018-01-16
NBIXNeurocrine Biosciences IncGorman Kevin CharlesCEOS - Sale$78.89-3,750336,357-1%-$295,820
2018-01-16
NBIXNeurocrine Biosciences IncGano KyleChief Business Development OffS - Sale$79.05-1,62574,871-2%-$128,460
2018-01-16
NBIXNeurocrine Biosciences IncBozigian Haig P.CHIEF DEVELOPMENT OFFICERS - Sale$79.12-1,625131,226-1%-$128,575
D
2018-01-16
AVXSAvexis, Inc.Litalien James JSrVP, Chief Reg, Quality OfficS - Sale+OE$106.52-5,0000-100%-$532,619
2018-01-16
AMGNAmgen IncHarper Sean EEVP, Research, DevelopmentS - Sale$185.62-1,52554,673-3%-$283,071
D
2018-01-12
XLRNAcceleron Pharma IncRovaldi ChristopherSVP, Program Mgmt, OpsS - Sale+OE$45.00-11,00024,701-31%-$495,000
D
2018-01-11
SGENSeattle Genetics Inc /waSiegall Clay BPres, CEOS - Sale+OE$51.71-18,832687,146-3%-$973,873
D
2018-01-11
GILDGilead Sciences IncAlton Gregg HEVP Comm, Acs ALA, Corp, Med AS - Sale+OE$79.00-30,00045,488-40%-$2,370,000
DM
2018-01-11
ATRAAtara Biotherapeutics, Inc.McGrath JohnEVP, CFOS - Sale+OE$24.35-37,00089,654-29%-$900,815
M
2018-01-10
ATRAAtara Biotherapeutics, Inc.Ciechanover Isaac E.CEOS - Sale$21.39-28,7001,103,753-3%-$613,843
2018-01-10
VYGRVoyager Therapeutics, Inc.Ravina BernardChief Medical OfficerS - Sale$16.40-3,6307,353-33%-$59,532
2018-01-05
CRSPCrispr Therapeutics AGEmster Kurt VonDirP - Purchase$22.75+65,9341,887,202+4%+$1,499,999

Real-time CSV? Options? Alerts? Contact us!
AAmended filing
DDerivative transaction in filing (usually option exercise)
EError detected in filing
MMultiple transactions in filing; earliest reported transaction date and weighted average transaction price
S - SaleSale of securities on an exchange or to another person
S - Sale+OESale of securities on an exchange or to another person (after option exercise)
F - TaxPayment of exercise price or tax liability using portion of securities received from the company
P - PurchasePurchase of securities on an exchange or from another person
Return to top